Aerobic Exercise Training and In Vivo Akt Activation Counteract Cancer Cachexia by Inducing a Hypertrophic Profile...

Area of Science:

• Oncology
• Physiology
• Molecular Biology

Background:

• Cancer cachexia is a severe syndrome causing muscle mass loss and dysfunction.
• Current treatments for cancer cachexia are limited, highlighting the need for better understanding of muscle plasticity during cancer progression.
• Aerobic exercise training (AET) is a complementary therapy, but its impact on muscle maintenance in cancer is not well-documented.

Purpose of the Study:

• To investigate the protective effects of prior AET on tumor-induced skeletal muscle wasting.
• To determine if in vivo Akt activation can induce hypertrophy and counteract cachexia in muscles.
• To explore the potential of stimulating skeletal muscle's hypertrophic capacity to combat cancer cachexia.

Main Methods:

• Investigated the impact of previous AET on tumor-induced muscle wasting.
• Analyzed the modulation of Akt/mTORC1 signaling and eukaryotic initiation factors (eIF2-α) in response to AET.
• Examined the effects of in vivo Akt activation on cachectic muscles to induce hypertrophy.

Main Results:

• Previous AET established a protective mechanism against muscle wasting by modulating Akt/mTORC1 signaling and eIF2-α.
• Akt-induced hypertrophy was sufficient to prevent or reverse cancer cachexia.
• Akt activation improved muscle functionality and modulated both Akt/mTORC1 and eIF-2α pathways.

Conclusions:

• Skeletal muscle retains the potential for hypertrophy, which can be stimulated by AET or gene therapy.
• Akt activation is a viable strategy to counteract cancer cachexia and improve muscle function.
• These findings offer new therapeutic avenues for managing cancer cachexia.